找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Advances in Diagnosis and Management of Ovarian Cancer; Samir A. Farghaly Book 2022Latest edition Springer Nature Switzerland AG 2022 Canc

[復(fù)制鏈接]
樓主: 遮陽傘
11#
發(fā)表于 2025-3-23 13:28:19 | 只看該作者
12#
發(fā)表于 2025-3-23 17:41:34 | 只看該作者
The Epidemiology of Vascular Dementiaerapy (EPIC) with paclitaxel is appropriate. Knowledge of the pharmacology of intraperitoneal chemotherapy agents is essential for selecting the proper drugs for use as HIPEC or EPIC. At the time of cytoreductive surgery with HIPEC, an intraperitoneal port is placed for subsequent combined bidirecti
13#
發(fā)表于 2025-3-23 20:18:50 | 只看該作者
https://doi.org/10.1007/978-3-642-76208-6e patients are subsequently treated with other agents, such as liposomal doxorubicin, gemcitabine, topotecan, or etoposide. The overall response rates to these other drugs are 10–25%. The identification of the genes and their protein products in ovarian cancer that contribute to the malignant phenot
14#
發(fā)表于 2025-3-24 00:57:05 | 只看該作者
15#
發(fā)表于 2025-3-24 03:31:39 | 只看該作者
16#
發(fā)表于 2025-3-24 06:56:59 | 只看該作者
17#
發(fā)表于 2025-3-24 11:17:20 | 只看該作者
18#
發(fā)表于 2025-3-24 16:23:32 | 只看該作者
J. H. Garcia,M. L. Anderson,J. H. Halsey Jr.s diagnosed in 2012 (4% of female cases and 2% of the total)..Of the subtypes, epithelial ovarian cancer is the most common, with other cancers such as germ cell or granulosa cell tumours occurring less frequently. High-grade serous is the most common epithelial ovarian cancer subtype..Ovarian cance
19#
發(fā)表于 2025-3-24 20:39:39 | 只看該作者
The Classification of Calcium Antagonistsian cancer is not associated with identifiable symptoms and screening efforts have not been able to significantly impact the mortality from this malignancy for multiple reasons. While work has been directed toward developing more sensitive tests, ovarian cancer appears to develop in the fallopian tu
20#
發(fā)表于 2025-3-25 01:56:49 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-13 08:10
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
瓦房店市| 泽库县| 会昌县| 修武县| 武隆县| 伊通| 尉犁县| 寿阳县| 景宁| 卢湾区| 陈巴尔虎旗| 张家口市| 平谷区| 岗巴县| 齐河县| 瓦房店市| 祥云县| 张家口市| 会昌县| 大悟县| 尉犁县| 余姚市| 册亨县| 屏南县| 咸阳市| 壶关县| 临邑县| 扬州市| 铜梁县| 开平市| 宁陕县| 科技| 礼泉县| 息烽县| 三河市| 惠安县| 康平县| 海阳市| 叙永县| 阜康市| 类乌齐县|